1,079
Views
12
CrossRef citations to date
0
Altmetric
Research Paper

Seroprevalence of hepatitis A virus in a cross-sectional study in Mexico

Implications for hepatitis A vaccination

, , , , , & show all
Pages 375-381 | Received 20 Aug 2012, Accepted 04 Nov 2012, Published online: 04 Jan 2013

References

  • Hepatitis A vaccines. Wkly Epidemiol Rec 2000; 75:38 - 44; PMID: 10693358
  • WHO. The immunological basis for immunization series: module 18: hepatitis A. 2011. Available at: http://whqlibdoc.who.int/publications/2011/9789241501422_eng.pdf. Accessed: February 10th, 2012.
  • Chodick G, Heymann AD, Ashkenazi S, Kokia E, Shalev V. Long-term trends in hepatitis A incidence following the inclusion of Hepatitis A vaccine in the routine nationwide immunization program. J Viral Hepat 2008; 15:Suppl 2 62 - 5; http://dx.doi.org/10.1111/j.1365-2893.2008.01032.x; PMID: 18837837
  • FitzSimons D, Hendrickx G, Vorsters A, Van Damme P. Hepatitis A and E: update on prevention and epidemiology. Vaccine 2010; 28:583 - 8; http://dx.doi.org/10.1016/j.vaccine.2009.10.136; PMID: 19925903
  • Bell BP, Feinstone SM. Hepatitis A Vaccine. In: Plotkin SA, Oreinstein WA, eds. Vaccines. 4th ed. Philadelphia, PA: Saunders, 2004:269-97.
  • Franco E, Meleleo C, Serino L, Sorbara D, Zaratti L, Hepatitis A. Hepatitis A: Epidemiology and prevention in developing countries. World J Hepatol 2012; 4:68 - 73; http://dx.doi.org/10.4254/wjh.v4.i3.68; PMID: 22489258
  • Cilla G, Pérez-Trallero E, Artieda J, Serrano-Bengoechea E, Montes M, Vicente D. Marked decrease in the incidence and prevalence of hepatitis A in the Basque Country, Spain, 1986-2004. Epidemiol Infect 2007; 135:402 - 8; http://dx.doi.org/10.1017/S0950268806006959; PMID: 16848926
  • Almuneef MA, Memish ZA, Balkhy HH, Qahtani M, Alotaibi B, Hajeer A, et al. Epidemiologic shift in the prevalence of Hepatitis A virus in Saudi Arabia: a case for routine Hepatitis A vaccination. Vaccine 2006; 24:5599 - 603; http://dx.doi.org/10.1016/j.vaccine.2006.04.038; PMID: 16757065
  • Sacy RG, Haddad M, Baasiri G, Khoriati A, Gerbaka BJ, Abu-Elyazeed R. Hepatitis a in Lebanon: a changing epidemiological pattern. Am J Trop Med Hyg 2005; 73:453 - 6; PMID: 16103621
  • Tosun S, Ertan P, Kasirga E, Atman U. Changes in seroprevalence of hepatitis A in children and adolescents in Manisa, Turkey. Pediatr Int 2004; 46:669 - 72; http://dx.doi.org/10.1111/j.1442-200x.2004.01969.x; PMID: 15660865
  • Jacobsen KH, Wiersma ST. Hepatitis A virus seroprevalence by age and world region, 1990 and 2005. Vaccine 2010; 28:6653 - 7; http://dx.doi.org/10.1016/j.vaccine.2010.08.037; PMID: 20723630
  • Ciocca M, Moreira-Silva SF, Alegría S, Galoppo MC, Ruttiman R, Porta G, et al. Hepatitis A as an etiologic agent of acute liver failure in Latin America. Pediatr Infect Dis J 2007; 26:711 - 5; http://dx.doi.org/10.1097/INF.0b013e3180f60bed; PMID: 17848883
  • Tapia-Conyer R, Santos JI, Cavalcanti AM, Urdaneta E, Rivera L, Manterola A, et al. Hepatitis A in Latin America: a changing epidemiologic pattern. Am J Trop Med Hyg 1999; 61:825 - 9; PMID: 10586919
  • Tanaka J. Hepatitis A shifting epidemiology in Latin America. Vaccine 2000; 18:Suppl 1 S57 - 60; http://dx.doi.org/10.1016/S0264-410X(99)00466-1; PMID: 10683550
  • García-Juárez I, Solórzano Santos F, Alvarez-y-Muñoz MT, Vázquez-Rosales JG. [Is there a shift in the epidemiology of hepatitis A in Mexican children?]. Rev Invest Clin 2008; 60:292 - 6; PMID: 18956550
  • Valdespino JL, Ruiz-Gomez J, Olaiz-Fernandez G, et al. Seroepidemiology of hepatitis A in Mexico. A detector of social inequity and monitor of immunization policies. Salud Publica Mex 2007; 49:Suppl. 3 S377 - 85; http://dx.doi.org/10.1590/S0036-36342007000900009
  • Vacchino MN. Incidence of Hepatitis A in Argentina after vaccination. J Viral Hepat 2008; 15:Suppl 2 47 - 50; http://dx.doi.org/10.1111/j.1365-2893.2008.01029.x; PMID: 18837834
  • Dora E, DeAntonio-Suarez R, Rodolfo C, et al. Impact of hepatitis A vaccination in Panama following universal immunization, 2000-2009. Sociedad Latinoamericana de Infectologia Pediatrica, May, 2011. Available: http://www.slipe.org/. Accessed: October 19th, 2011.
  • Van Herck K, Jacquet JM, Van Damme P. Antibody persistence and immune memory in healthy adults following vaccination with a two-dose inactivated hepatitis A vaccine: long-term follow-up at 15 years. J Med Virol 2011; 83:1885 - 91; http://dx.doi.org/10.1002/jmv.22200; PMID: 21915861
  • Hendrickx G, Van Herck K, Vorsters A, Wiersma S, Shapiro C, Andrus JK, et al. Has the time come to control hepatitis A globally? Matching prevention to the changing epidemiology. J Viral Hepat 2008; 15:Suppl 2 1 - 15; http://dx.doi.org/10.1111/j.1365-2893.2008.01022.x; PMID: 18837827
  • Advisory Committee on Immunization Practices (ACIP). Fiore AE, Wasley A, Bell BP. Prevention of hepatitis A through active or passive immunization: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2006; 55:1 - 23
  • Krebs LS, Ranieri TM, Kieling CO, Ferreira CT, Silveira TR. Shifting susceptibility to hepatitis A among children and adolescents over the past decade. J Pediatr (Rio J) 2011; 87:213 - 8; PMID: 21468471
  • Moisseeva AV, Marichev IL, Biloschitchkay NA, Pavlenko KI, Novik LV, Kovinko LV, et al. Hepatitis A seroprevalence in children and adults in Kiev City, Ukraine. J Viral Hepat 2008; 15:Suppl 2 43 - 6; http://dx.doi.org/10.1111/j.1365-2893.2008.01028.x; PMID: 18837833
  • World Health Organization Media Center. Hepatitis A. Available: http://www.who.int/mediacentre/factsheets/fs328/en/index.html. Accessed: October 4th, 2012.
  • Bell BP. Global epidemiology of hepatitis A: Implications for control strategies. In: Margolis HS, Alter MJ, Liang TJ, Dienstag JL, editors. Viral hepatitis and liver disease. London: International Medical Press; 2002:9-14.
  • Markus JR, Cruz CR, Maluf EMCP, Tahan TT, Hoffmann MM. Seroprevalence of hepatitis A in children and adolescents. J Pediatr (Rio J) 2011; 87:419 - 24; PMID: 21842115
  • Los Pueblos Indígenas en Áreas Urbanas y la Migración. Retos y Oportunidades. United Nations. Available: http://www.un.org/esa/socdev/unpfii/documents/6_session_factsheet2_es.pdf. Accessed: October 8th, 2012.
  • Olaiz-Fernández G, Rivera-Dommarco J, Shamah-Levy T, et al. Encuesta Nacional de Salud y Nutrición 2006. Cuernavaca, México: Instituto Nacional de Salud Pública, 2006. Available: http://www.insp.mx/ensanut/ensanut2006.pdf. Accessed: October 8th, 2012.
  • McMahon BJ, Beller M, Williams J, Schloss M, Tanttila H, Bulkow L. A program to control an outbreak of hepatitis A in Alaska by using an inactivated hepatitis A vaccine. Arch Pediatr Adolesc Med 1996; 150:733 - 9; http://dx.doi.org/10.1001/archpedi.1996.02170320079014; PMID: 8673200
  • Príkazský V, Oleár V, Cernoch A, Safary A, André FE. Interruption of an outbreak of hepatitis A in two villages by vaccination. J Med Virol 1994; 44:457 - 9; http://dx.doi.org/10.1002/jmv.1890440427; PMID: 7897381
  • Craig AS, Watson B, Zink TK, Davis JP, Yu C, Schaffner W. Hepatitis A outbreak activity in the United States: responding to a vaccine-preventable disease. Am J Med Sci 2007; 334:180 - 3; http://dx.doi.org/10.1097/MAJ.0b013e3181425411; PMID: 17873531
  • Consejo Nacional De Vacunacion. Manual de vacunacion 2008-2009. Available: http://www.scribd.com/doc/16701329/Manual-Vacunacion-Mexico-20082009. Accessed: October 8th, 2012.
  • Ellis A, Rüttimann RW, Jacobs RJ, Meyerhoff AS, Innis BL. Cost-effectiveness of childhood hepatitis A vaccination in Argentina: a second dose is warranted. Rev Panam Salud Publica 2007; 21:345 - 56; http://dx.doi.org/10.1590/S1020-49892007000500002; PMID: 17761046
  • Rein DB, Hicks KA, Wirth KE, Billah K, Finelli L, Fiore AE, et al. Cost-effectiveness of routine childhood vaccination for hepatitis A in the United States. Pediatrics 2007; 119:e12 - 21; http://dx.doi.org/10.1542/peds.2006-1573; PMID: 17200237
  • Wasley A, Fiore A, Bell BP. Hepatitis A in the era of vaccination. Epidemiol Rev 2006; 28:101 - 11; http://dx.doi.org/10.1093/epirev/mxj012; PMID: 16775039
  • Armstrong GL, Billah K, Rein DB, Hicks KA, Wirth KE, Bell BP. The economics of routine childhood hepatitis A immunization in the United States: the impact of herd immunity. Pediatrics 2007; 119:e22 - 9; http://dx.doi.org/10.1542/peds.2006-1572; PMID: 17200247
  • Dagan R, Leventhal A, Anis E, Slater P, Ashur Y, Shouval D. Incidence of hepatitis A in Israel following universal immunization of toddlers. JAMA 2005; 294:202 - 10; http://dx.doi.org/10.1001/jama.294.2.202; PMID: 16014594
  • Domínguez A, Oviedo M, Carmona G, Batalla J, Bruguera M, Salleras L, et al. Impact and effectiveness of a mass hepatitis A vaccination programme of preadolescents seven years after introduction. Vaccine 2008; 26:1737 - 41; http://dx.doi.org/10.1016/j.vaccine.2008.01.048; PMID: 18325642
  • Effelterre TV, De Antonio-Suarez R. Cassidy Adrian, Romano-Mazzotti L, Marano C. Model-based projections of the population-level impact of hepatitis A vaccination in Mexico. Hum Vaccin Immunother 2012; 8:1099 - 108
  • Santos JI. El Programa Nacional de Vacunacion: orgullo de Mexico. Rev Fac Med UNAM 2002; 45:142 - 53
  • Mesa redonda XXVI Vacunas para la edad adolescente. Salud Publica Mex 2007; 49:suppl 1 322 - 4

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.